Calidi Biotherapeutics announces 1-for-16 reverse stock split effective July 31 - CLDI News | RalliesCalidi Biotherapeutics announces 1-for-16 reverse stock split effective July 31
C
CLDI• Reverse stock split details
- Calidi Biotherapeutics will implement a 1-for-16 reverse stock split of its common stock.
- Shares are expected to begin trading on a split-adjusted basis on July 31, 2026 on NYSE American under CLDI.
- Fractional shares will be rounded up to the nearest whole share at the participant level.
- New post-split CUSIP: 320703 507.
OST
•
